How are hsCRP and menopause related?

The relationship between hsCRP (high-sensitivity C-reactive protein) and menopause is well-established in medical literature, though not covered in the provided MyBody-X contexts. As women transition through menopause, declining estrogen levels promote visceral fat accumulation and a pro-inflammatory state. hsCRP, a systemic inflammation marker, often rises during perimenopause and postmenopause, independently of traditional cardiovascular risk factors. This elevation is linked to increased risks of cardiovascular disease, insulin resistance, and bone loss. However, causality is complex: hormonal shifts, weight gain, and aging overlap. An hsCRP test can offer additional risk stratification for postmenopausal women but should not replace clinical evaluation. Since the MyBody-X knowledge base lacks specific data on hsCRP or menopause, this answer draws on general medical knowledge. Consumer DNA or lab tests may provide complementary insights (e.g., inflammation-related SNPs), but their clinical utility for menopause-related hsCRP interpretation remains limited without professional guidance.